2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis care & research · 2021 · 812 citations · Joel Kremer
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 669 citations · Joel Kremer
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 174 citations · Lee Shapiro
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 132 citations · Lee Shapiro
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis care & research · 2024 · 111 citations · Lee Shapiro
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Annals of the rheumatic diseases · 2021 · 228 citations ·
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis.
Annals of the rheumatic diseases · 2022 · 175 citations · Alan Kivitz
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Annals of the rheumatic diseases · 2021 · 208 citations · Alan Kivitz